CMS Open Payments · Program Year 2024
Delaware
Delaware received $4,260,761.19 in pharmaceutical-industry payments to 2,282 physicians and 5 teaching hospitals across 52,483 transactions.
- $4.3M
- Total payments
- $2.9M
- To physicians
- $596.9K
- To teaching hospitals
- #46
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $4.3M in payments to 2,282 physicians and 5 teaching hospitals in Delaware. That ranks Delaware #46 of 59 states and territories (0.0% of the US total), averaging $1.3K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Delaware pairs modest payment volume with a physician-heavy payment mix.
- #46
- of 59 states
- 0.0%
- of the national total
- 68.5%
- to physicians vs. hospitals
- 2,282
- physicians paid
What the Data Shows for Delaware
Delaware's Open Payments file is hospital-weighted: 14.0% of $4.3M went to 5 teaching hospitals ($119.4K each), with 68.5% on 2,282 physicians.
On the national dollar ranking it is #46 of 59, so the mix skew is larger than the volume rank. Average transaction $81.18. Leading nature of payment: "Food and Beverage" at $1.3M (30.1% of the state file; top-three natures 70.7%).
Delaware sits in the 24th percentile (lower-volume tier). Just above: New Mexico ($6.7M). Just below: Maine ($3.5M). For context: top-ranked California ($342.4M) is 80.4× larger than Delaware. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Delaware are distributed between physicians and teaching hospitals.
Physician Payments
$2.9M
68.5% of total · 2,282 recipients · $1.3K avg
Teaching Hospital Payments
$596.9K
14.0% of total · 5 hospitals · $119.4K avg
Payment Breakdown by Type
Delaware has 15 types of pharmaceutical payments. "Food and Beverage" accounts for 30.1%.
Nature concentration in Delaware
Top three Open Payments natures are 70.7% of state dollars; residual is every other reported nature
Payment categories in Delaware
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Food and Beverage | $1.3M | 49,804 | 30.1% |
| Consulting Fee | $928.8K | 377 | 21.8% |
| Compensation for Services Other Than Consulting | $802.0K | 381 | 18.8% |
| Travel and Lodging | $279.0K | 1,102 | 6.5% |
| Long-Term Medical Supply or Device Loan | $267.8K | 35 | 6.3% |
| Royalty or License | $209.6K | 21 | 4.9% |
| Space Rental or Facility Fees | $179.9K | 65 | 4.2% |
| Education | $124.3K | 535 | 2.9% |
| Grant | $53.3K | 5 | 1.3% |
| Honoraria | $44.3K | 42 | 1.0% |
| Compensation for Faculty or Speaker (Medical Education) | $38.7K | 34 | 0.9% |
| Debt Forgiveness | $32.8K | 12 | 0.8% |
| Gift | $10.3K | 59 | 0.2% |
| Charitable Contribution | $7.5K | 2 | 0.2% |
| Entertainment | $270.15 | 9 | 0.0% |
Read with this Delaware Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: New Mexico ($6.7M)
- Next lower total: Maine ($3.5M)
- Nearest physician-share mix: Arkansas (68.1% to physicians)
- Nearest physician-share mix: Alaska (67.9% to physicians)
- Nearest physician-share mix: Montana (70.2% to physicians)
- National catalog for leading nature here: Food and Beverage (30.1% of Delaware)
- State payment rankings (includes Delaware at #46)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Delaware totals can and cannot tell you
The aggregate payment figure for Delaware measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.